ANASTROZOLE Side Effects

7022114-2 | Skin Discolouration
on Sep 20, 2010 Female patient from , 74 years of age, was diagnosed with breast lump removal and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: skin discolouration. Anastrozole dosage: 1 Mg.

7011865-1 | Osteoporosis, Radius Fracture
Patient was taking Anastrozole (View Usage). Patient had the following side effects: osteoporosis (What is osteoporosis?), radius fracture on Sep 14, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Anastrozole dosage: .

7011859-6 | Hip Fracture
Adverse event was reported on Sep 14, 2010 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 76 years of age, After Anastrozole was administered, patient had the following side effects: hip fracture.

7009940-0 | Anxiety, Flushing, Heart Rate Increased, Product Substitution Issue, Pruritus, Psychomotor Hyperactivity
on Sep 03, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), flushing, heart rate increased, product substitution issue, pruritus, psychomotor hyperactivity. Anastrozole dosage: 1.00 Mg-1.00 Per 1.0 Days Oral. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).


7006631-7 | Hypersensitivity, Lip Swelling, Swelling Face
on Sep 21, 2010 Female patient from UNITED STATES , 64 years of age, weighting 154.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient had the following side effects: hypersensitivity, lip swelling, swelling face. Anastrozole dosage: 1 Mg 1/day By Mouth.

6913964-9 | Anxiety, Product Substitution Issue, Refusal Of Treatment By Patient
Patient was taking Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: anxiety (What is anxiety?), product substitution issue, refusal of treatment by patient on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 180.0 lb, was diagnosed with breast cancer (What is breast cancer?), oestrogen receptor assay positive and. Anastrozole dosage: 0.5 Mg Daily Po. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FENTANYL 75 (View Fentanyl-75 Review and Fentanyl-75 Label ), CODEINE LIQUID (View Codeine Liquid Review and Codeine Liquid Label ).

6857306-6 |
Adverse event was reported on Mar 23, 2010 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), osteoporosis (What is osteoporosis?) and. Location: GERMANY , 76 years of age, . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NORVASC (View Norvasc Review and Norvasc Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METFORMIN (View Metformin Review and Metformin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6673670-5 | Arthralgia
on Mar 30, 2010 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient had the following side effects: arthralgia. Anastrozole dosage: .

6660771-0 | Arthralgia, Mobility Decreased
on Mar 24, 2010 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: arthralgia, mobility decreased. Anastrozole dosage: .

6655086-0 |
Patient was taking Anastrozole (View Usage). on Mar 23, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, was diagnosed with breast cancer (What is breast cancer?), osteoporosis (What is osteoporosis?) and. Anastrozole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NORVASC (View Norvasc Review and Norvasc Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6554238-8 | Meniscus Lesion
Adverse event was reported on Jan 26, 2010 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: GERMANY , weighting 136.7 lb, Patient had the following side effects: meniscus lesion.

6448167-8 | Blood Cholesterol Abnormal, Macular Hole
on Nov 11, 2009 Female patient from HONG KONG , 59 years of age, was diagnosed with breast cancer (What is breast cancer?), hypercholesterolaemia and was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: blood cholesterol abnormal, macular hole. Anastrozole dosage: . During the same period patient was treated with EXEMESTANE (View Exemestane Review and Exemestane Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ).

6380639-7 | Henoch-schonlein Purpura
on Sep 21, 2009 Female patient from ITALY , 55 years of age, was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: henoch-schonlein purpura. Anastrozole dosage: . Patient was hospitalized.

6336114-9 | Disease Progression, Haemorrhage Intracranial, Metastases To Central Nervous System
Patient was taking Anastrozole (View Usage). Patient had the following side effects: disease progression, haemorrhage intracranial, metastases to central nervous system on Aug 28, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 205.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Anastrozole dosage: 1 Mg Po Qd. During the same period patient was treated with AZDO530 (175mg Po Qd) (View Azdo530 Review and Azdo530 Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ). Patient was hospitalized.

6332447-0 | Anxiety, Aphasia, Asthenia, Cognitive Disorder, Depressed Mood, Disturbance In Attention, Dry Eye, Dry Mouth, Dysphagia
Adverse event was reported on Aug 27, 2009 by a Female patient taking Anastrozole (View Usage) (Dosage: 1mg Daily Po) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 57 years of age, weighting 140.9 lb, After Anastrozole was administered, patient had the following side effects: anxiety (What is anxiety?), aphasia (What is aphasia?), asthenia, cognitive disorder, depressed mood, disturbance in attention, dry eye, dry mouth, dysphagia. During the same period patient was treated with OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ).

6330510-1 | Apathy, Arthralgia, Cataract, Epistaxis, Fatigue, Hot Flush, Muscle Spasms, Visual Acuity Reduced
on Aug 18, 2009 Female patient from MEXICO , weighting 176.4 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: apathy, arthralgia, cataract (What is cataract?), epistaxis, fatigue, hot flush, muscle spasms, visual acuity reduced. Anastrozole dosage: . During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized and became disabled.

6295985-5 | Neuropathy Peripheral, Paraesthesia
on Jul 28, 2009 Female patient from UNITED KINGDOM , 61 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient had the following side effects: neuropathy peripheral, paraesthesia. Anastrozole dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), ANTIDEPRESSANT NOS (View Antidepressant Nos Review and Antidepressant Nos Label ), TOLTERODINE TARTRATE (View Tolterodine Tartrate Review and Tolterodine Tartrate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), STATIN (View Statin Review and Statin Label ).

6270412-2 | Alveolitis Allergic, Dyspnoea
Patient was taking Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: alveolitis allergic, dyspnoea on Jul 07, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 63 years of age, . Anastrozole dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6234749-5 | Alopecia, Mental Disorder
Adverse event was reported on Jun 10, 2009 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), hypertension and. Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, mental disorder. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6222676-9 | Bone Marrow Disorder, Leukopenia
on Jun 09, 2009 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient had the following side effects: bone marrow disorder, leukopenia. Anastrozole dosage: 1mg.

6171265-3 | Depression, Suicidal Ideation, Withdrawal Syndrome
on Apr 24, 2009 Female patient from UNITED KINGDOM , 56 years of age, weighting 145.5 lb, was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: depression (What is depression?), suicidal ideation, withdrawal syndrome. Anastrozole dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (50 Ug) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6064351-X | Blood Creatinine Increased, Culture Urine Positive, Escherichia Infection, Haemoglobin Decreased, Limb Discomfort, Oedema Peripheral, Platelet Count Decreased, Pyrexia
Patient was taking Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, culture urine positive, escherichia infection, haemoglobin decreased, limb discomfort, oedema peripheral, platelet count decreased, pyrexia on Feb 03, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 205.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Anastrozole dosage: 1mg Po Qd. During the same period patient was treated with AZD0530 (175 Mg Po Qd) (View Azd0530 Review and Azd0530 Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MOBIC (View Mobic Review and Mobic Label ), MORPHINE SULPHATE ER (View Morphine Sulphate Er Review and Morphine Sulphate Er Label ), ZOMETA (View Zometa Review and Zometa Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6064349-1 | Bacteria Blood Identified, Bacteria Urine Identified, Escherichia Infection, Haemoglobin Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Feb 03, 2009 by a Female patient taking Anastrozole (View Usage) (Dosage: 1mg Po Qd) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 53 years of age, weighting 205.0 lb, Patient had the following side effects: bacteria blood identified, bacteria urine identified, escherichia infection, haemoglobin decreased, platelet count decreased, white blood cell count decreased. During the same period patient was treated with AZDO530 (175mg Po Qd) (View Azdo530 Review and Azdo530 Label ). Patient was hospitalized.

5946889-6 | Hypertension, Migraine, Nausea
on Nov 04, 2008 Female patient from BRAZIL , 65 years of age, weighting 194.0 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, diabetes mellitus and was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: hypertension, migraine (What is migraine?), nausea (What is nausea?). Anastrozole dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GENUVIA (View Genuvia Review and Genuvia Label ).

5945322-8 | Rhabdomyosarcoma
on Oct 29, 2008 Female patient from POLAND , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyosarcoma. Anastrozole dosage: . During the same period patient was treated with TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ). Patient was hospitalized.

5934032-9 | Cutaneous Vasculitis
Patient was taking Anastrozole (View Usage). Patient had the following side effects: cutaneous vasculitis on Oct 23, 2008 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with breast cancer (What is breast cancer?), toxic nodular goitre and. Anastrozole dosage: . During the same period patient was treated with FULVESTRANT (View Fulvestrant Review and Fulvestrant Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), LETROZOLE (View Letrozole Review and Letrozole Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), METHIMAZOLE (View Methimazole Review and Methimazole Label ).

5925705-2 | Hypertension, Migraine, Nausea, Product Quality Issue
Adverse event was reported on Oct 13, 2008 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), hypertension, diabetes mellitus and. Location: BRAZIL , 65 years of age, weighting 194.0 lb, After Anastrozole was administered, patient had the following side effects: hypertension, migraine (What is migraine?), nausea (What is nausea?), product quality issue. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GENUVIA (View Genuvia Review and Genuvia Label ).

5875436-2 | Alopecia, Arthralgia, Blood Pressure Increased, Cholelithiasis, Nausea, Pain In Extremity
on Sep 02, 2008 Female patient from BRAZIL , 86 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, arthralgia, blood pressure increased, cholelithiasis, nausea (What is nausea?), pain in extremity. Anastrozole dosage: . During the same period patient was treated with ALDOMET (View Aldomet Review and Aldomet Label ). Patient was hospitalized.

5809124-5 | Cerebral Infarction
on Jul 03, 2008 Female patient from JAPAN , weighting 92.59 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). Patient had the following side effects: cerebral infarction. Anastrozole dosage: . During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), KALLIKREIN (View Kallikrein Review and Kallikrein Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), CIRCULETIN (View Circuletin Review and Circuletin Label ), KARY UNI (View Kary Uni Review and Kary Uni Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5788488-5 | Cystitis, Dehydration, Disorientation, Upper Respiratory Tract Infection, Urinary Tract Infection
Patient was taking Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: cystitis, dehydration, disorientation, upper respiratory tract infection, urinary tract infection (What is urinary tract infection?) on Jun 25, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Anastrozole dosage: 1 Pill A Day. Patient was hospitalized.

5787374-4 | Ovarian Disorder
Adverse event was reported on Jun 16, 2008 by a Female patient taking Anastrozole (View Usage) (Dosage: ) . Location: NETHERLANDS , weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: ovarian disorder. Patient was hospitalized.

5727429-3 | Anorexia, Autoimmune Hepatitis, Malaise, Pancytopenia, Pyrexia
on May 02, 2008 Female patient from AUSTRALIA , 60 years of age, weighting 126.1 lb, was diagnosed with breast neoplasm and was treated with Anastrozole (View Usage). Patient had the following side effects: anorexia, autoimmune hepatitis, malaise, pancytopenia, pyrexia. Anastrozole dosage: . During the same period patient was treated with HERBAL MEDICINES (View Herbal Medicines Review and Herbal Medicines Label ), TAMOXIFEN CITRATE (Long Term) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ).

5682703-4 | Breast Cancer Metastatic, Confusional State, Constipation, Proctalgia, Pulmonary Embolism
on Mar 26, 2008 Female patient from UNITED STATES , 53 years of age, weighting 141.1 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: breast cancer metastatic, confusional state, constipation (What is constipation?), proctalgia, pulmonary embolism (What is pulmonary embolism?). Anastrozole dosage: 1 Mg Po Qd. During the same period patient was treated with VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), OXYBUTININ (View Oxybutinin Review and Oxybutinin Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), DOCUSATE (View Docusate Review and Docusate Label ).

5538240-0 | Photopsia, Vision Blurred, Vitreous Haemorrhage
Patient was taking Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: photopsia, vision blurred, vitreous haemorrhage on Dec 05, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 75 years of age, weighting 202.8 lb, was diagnosed with hiatus hernia, osteoporosis (What is osteoporosis?) and. Anastrozole dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

5530897-3 | Erythema Nodosum
Adverse event was reported on Nov 26, 2007 by a Female patient taking Anastrozole (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, Patient had the following side effects: erythema nodosum.

5530675-5 | Ovarian Disorder
on Nov 27, 2007 Female patient from NETHERLANDS , weighting 145.5 lb, was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: ovarian disorder. Anastrozole dosage: . Patient was hospitalized.

5505557-5 | Secondary Hypertension
on Oct 22, 2007 Female patient from UNITED KINGDOM , 54 years of age, weighting 109.1 lb, was diagnosed with breast cancer metastatic and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: secondary hypertension. Anastrozole dosage: . During the same period patient was treated with EXEMESTANE (View Exemestane Review and Exemestane Label ).

5475908-9 | Facial Palsy, Gait Disturbance, Muscular Weakness, Musculoskeletal Stiffness
Patient was taking Anastrozole (View Usage). Patient had the following side effects: facial palsy, gait disturbance, muscular weakness, musculoskeletal stiffness on Sep 24, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Anastrozole dosage: .

5472608-6 | Pulmonary Embolism
Adverse event was reported on Nov 10, 2006 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 80 years of age, After Anastrozole was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PAROXETINE (View Paroxetine Review and Paroxetine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ).

5361529-5 | Osteonecrosis
on Jun 12, 2007 Female patient from LITHUANIA , 50 years of age, was diagnosed with metastases to bone and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Anastrozole dosage: 1 Mg, Unk. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5308730-4 | Depression, Suicidal Ideation
on Apr 13, 2007 Female patient from UNITED KINGDOM , 56 years of age, weighting 145.5 lb, was treated with Anastrozole (View Usage). Patient had the following side effects: depression (What is depression?), suicidal ideation. Anastrozole dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5284906-X | Depression, Suicidal Ideation
Patient was taking Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: depression (What is depression?), suicidal ideation on Mar 28, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, weighting 145.5 lb, . Anastrozole dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5283331-5 | Optic Neuritis, Pain, Visual Acuity Reduced
Adverse event was reported on Mar 21, 2007 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 41 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: optic neuritis, pain (What is pain?), visual acuity reduced.

5223896-2 | Migraine
on Jan 19, 2007 Female patient from UNITED KINGDOM , 50 years of age, was diagnosed with breast cancer (What is breast cancer?), osteoporosis prophylaxis and was treated with Anastrozole (View Usage). Patient had the following side effects: migraine (What is migraine?). Anastrozole dosage: . During the same period patient was treated with ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

5170044-3 | International Normalised Ratio Increased
on Dec 01, 2006 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: international normalised ratio increased. Anastrozole dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CORACTEN XL (View Coracten Xl Review and Coracten Xl Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5082745-6 | Bradycardia, Syncope
Patient was taking Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, syncope on Aug 16, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 268.7 lb, was diagnosed with hypogonadism and. Anastrozole dosage: 1 Mg Po Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LORATADINE (View Loratadine Review and Loratadine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ). Patient was hospitalized.

5075551-X | Musculoskeletal Pain, Pelvic Pain, Sacroiliitis
Adverse event was reported on Jul 27, 2006 by a Female patient taking Anastrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), hot flush and. Location: UNITED KINGDOM , 47 years of age, Patient had the following side effects: musculoskeletal pain, pelvic pain (What is pelvic pain?), sacroiliitis. During the same period patient was treated with MEGACE (View Megace Review and Megace Label ).

5040192-7 | Back Pain, Rash, Swelling Face
on Jun 20, 2006 Female patient from UNITED KINGDOM , weighting 198.4 lb, was treated with Anastrozole (View Usage). After Anastrozole was administered, patient had the following side effects: back pain (What is back pain?), rash (What is rash?), swelling face. Anastrozole dosage: .

5035128-9 | Osteitis, Osteonecrosis, Tooth Extraction
on Dec 07, 2005 Female patient from GERMANY , 48 years of age, weighting 97.00 lb, was diagnosed with breast cancer metastatic and was treated with Anastrozole (View Usage). Patient experienced the following unwanted or unexpected effects: osteitis, osteonecrosis (What is osteonecrosis?), tooth extraction. Anastrozole dosage: 1 Mg, Qd. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ), TAXOTERE (35 Mg/m2, Qw) (View Taxotere Review and Taxotere Label ), DEXAMETHASONE TAB (20 Mg, Qw) (View Dexamethasone Tab Review and Dexamethasone Tab Label ).

5033315-7 | Abdominal Pain Upper, Chest Pain, Diarrhoea, Disease Progression, Dyspnoea, Headache, Nausea, Pleural Effusion, Somnolence
Patient was taking Anastrozole (View Usage). Patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), diarrhoea, disease progression, dyspnoea, headache (What is headache?), nausea (What is nausea?), pleural effusion, somnolence on Mar 21, 2006 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 79.37 lb, was diagnosed with breast cancer metastatic and. Anastrozole dosage: . Patient was hospitalized.